Novartis Investigative Site

HUS, Finland 00029

0 studies enrolling now · 1 studies all time

What they study most

Anklyosing Spondylitis

Studies at this site

• 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis — Completed